NO20034007L - N-fenylarylsulfonamidforbindelse, legemiddel inneholdende forbindelsen somaktiv bestanddel, mellomprodukt for forbindelsen, ogfremgangsmåter for fremstilling av samme - Google Patents

N-fenylarylsulfonamidforbindelse, legemiddel inneholdende forbindelsen somaktiv bestanddel, mellomprodukt for forbindelsen, ogfremgangsmåter for fremstilling av samme

Info

Publication number: NO20034007L
Authority: NO; Norway
Prior art keywords: compound; methyl; preparing; processes; active ingredient
Prior art date: 2001-03-12

Application number

NO20034007A

Other languages

English (en)

Other versions

NO20034007D0 (no

NO329682B1 (no

Inventor

Atsushi Naganawa

Tetsuji Saitoh

Kaoru Kobayashi

Takayuki Maruyama

Yoshihiko Nakai

Yoshihiko Hashimoto

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-12

Filing date

2003-09-10

Publication date

2003-11-12

2003-09-10 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2003-09-10 Publication of NO20034007D0 publication Critical patent/NO20034007D0/no

2003-11-12 Publication of NO20034007L publication Critical patent/NO20034007L/no

2010-11-29 Publication of NO329682B1 publication Critical patent/NO329682B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/64—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Neurology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Furan Compounds (AREA)

NO20034007A 2001-03-12 2003-09-10 N-fenylarylsulfonamidforbindelse, og antagonist av EP1 reseptor og farmasoytisk preparat omfattende forbindelsen som aktiv bestanddel NO329682B1 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2001068498		2001-03-12
JP2001281569		2001-09-17
JP2002007760		2002-01-16
PCT/JP2002/002245 WO2002072564A1 (en)	2001-03-12	2002-03-11	N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same

Publications (3)

Publication Number	Publication Date
NO20034007D0 NO20034007D0 (no)	2003-09-10
NO20034007L true NO20034007L (no)	2003-11-12
NO329682B1 NO329682B1 (no)	2010-11-29

Family

ID=27346214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034007A NO329682B1 (no)	2001-03-12	2003-09-10	N-fenylarylsulfonamidforbindelse, og antagonist av EP1 reseptor og farmasoytisk preparat omfattende forbindelsen som aktiv bestanddel

Country Status (24)

Country	Link
US (3)	US7235667B2 (no)
EP (2)	EP1612208B1 (no)
JP (3)	JP3555620B2 (no)
KR (1)	KR100886854B1 (no)
CN (1)	CN1294126C (no)
AT (2)	ATE522513T1 (no)
AU (1)	AU2002238855B2 (no)
BR (1)	BR0208027A (no)
CA (1)	CA2439604C (no)
CZ (1)	CZ304035B6 (no)
DE (1)	DE60220255T2 (no)
DK (2)	DK1369419T3 (no)
ES (1)	ES2286230T3 (no)
HU (1)	HU230056B1 (no)
IL (2)	IL157701A0 (no)
MX (1)	MXPA03008134A (no)
NO (1)	NO329682B1 (no)
NZ (1)	NZ528120A (no)
PL (1)	PL218750B1 (no)
PT (2)	PT1612208E (no)
RU (1)	RU2299202C2 (no)
TW (1)	TWI317359B (no)
WO (1)	WO2002072564A1 (no)
ZA (1)	ZA200306884B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2004022549A1 (ja) *	2002-09-09	2005-12-22	小野薬品工業株式会社	４−メチル−１，３−チアゾール−２−イルスルホニルハライドの製造方法
CN100408570C (zh) *	2003-01-29	2008-08-06	阿斯特兰德英国有限公司	Ep4受体拮抗剂
GB0317500D0 (en) *	2003-07-25	2003-08-27	Pfizer Ltd	Treatment of bph
WO2005000356A1 (ja) *	2003-06-27	2005-01-06	Ono Pharmaceutical Co., Ltd.	尿路疾患治療剤
GB0401334D0 (en) *	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
US20080033018A1 (en) *	2004-07-05	2008-02-07	Chugai Seiyaku Kabushiki Kaisha	Therapeutic Agents For Overactive Bladder
JP2008189549A (ja) *	2005-05-12	2008-08-21	Astellas Pharma Inc	カルボン酸誘導体またはその塩
JP2009057282A (ja) *	2005-12-19	2009-03-19	Astellas Pharma Inc	カルボン酸誘導体又はその塩
TW200817319A (en)	2006-08-10	2008-04-16	Astellas Pharma Inc	Sulfonamide compound or salt thereof
BRPI0807942A2 (pt) *	2007-02-16	2014-07-01	Ono Pharmaceutical Co	Agente terapêutico para distúrbio de excreção urinária
ATE554070T1 (de) *	2007-08-01	2012-05-15	Taisho Pharmaceutical Co Ltd	Hemmer der s1p1-bindung
SG157299A1 (en)	2008-05-09	2009-12-29	Agency Science Tech & Res	Diagnosis and treatment of kawasaki disease
CN102076660B (zh) *	2008-06-23	2014-01-08	安斯泰来制药有限公司	磺胺化合物或其盐
TW201107309A (en) *	2009-07-27	2011-03-01	Kissei Pharmaceutical	Indole derivatives, or the pharmaceutically acceptable salts
CN103209960A (zh) *	2010-07-26	2013-07-17	百时美施贵宝公司	用作cyp17抑制剂的磺酰胺化合物
JP5363636B2 (ja) *	2011-10-21	2013-12-11	ファイザー・リミテッド	新規な塩および医学的使用
US20140039004A1 (en) *	2012-07-31	2014-02-06	Ono Pharmaceutical Co., Ltd.	Method of treating of gastroesophageal reflux disease
CN106660063B (zh) *	2014-04-30	2019-06-18	佩纳尔维工业有限公司	用于将液体应用于不同形状的盖子上的可编程同心头
SG11201803867TA (en) *	2015-11-13	2018-06-28	Daewoong Pharmaceutical Co Ltd	Sodium channel blocker
RU2659955C1 (ru) *	2017-10-26	2018-07-04	Галина Ильхамовна Лукина	Способ диагностики высоких гастроэзофагеальных рефлюксов

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2419923A1 (de) *	1973-04-28	1974-11-28	Fujisawa Pharmaceutical Co	Sulfonsaeureester, verfahren zu deren herstellung und verwendung derselben als kondensationsmittel
JPS5748534B2 (no)	1974-03-04	1982-10-16
DE2555048A1 (de) *	1975-12-06	1977-06-30	Pfersee Chem Fab	Verfahren und vorrichtung zur herstellung bestaendiger, waessriger emulsionen wasserunloeslicher substanzen
JPS5293469A (en)	1976-02-02	1977-08-05	Fuji Photo Film Co Ltd	Method of curing gelatin
JPH05293469A (ja)	1992-04-17	1993-11-09	Toda Constr Co Ltd	滅菌精製水の製造方法およびその装置
NZ247440A (en) *	1992-05-06	1995-04-27	Squibb & Sons Inc	Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
TW523506B (en)	1996-12-18	2003-03-11	Ono Pharmaceutical Co	Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
WO2000069465A1 (en) *	1999-05-12	2000-11-23	Ono Pharmaceutical Co., Ltd.	Anticancer agents containing ep1 antagonists as the active ingredient
WO2001008674A1 (en)	1999-07-29	2001-02-08	Ono Pharmaceutical Co., Ltd.	Sulfonamide derivatives and remedies for allodynia
US7335776B2 (en) *	2001-03-14	2008-02-26	Ono Pharmaceutical Co., Ltd.	Remedies for depression containing EP1 antagonist as the active ingredient

2002
- 2002-03-11 JP JP2002571480A patent/JP3555620B2/ja not_active Expired - Fee Related
- 2002-03-11 DE DE60220255T patent/DE60220255T2/de not_active Expired - Lifetime
- 2002-03-11 EP EP05109059A patent/EP1612208B1/en not_active Expired - Lifetime
- 2002-03-11 PT PT05109059T patent/PT1612208E/pt unknown
- 2002-03-11 EP EP02705096A patent/EP1369419B1/en not_active Expired - Lifetime
- 2002-03-11 CA CA2439604A patent/CA2439604C/en not_active Expired - Fee Related
- 2002-03-11 CZ CZ20032452A patent/CZ304035B6/cs not_active IP Right Cessation
- 2002-03-11 DK DK02705096T patent/DK1369419T3/da active
- 2002-03-11 KR KR1020037011921A patent/KR100886854B1/ko not_active Expired - Fee Related
- 2002-03-11 PT PT02705096T patent/PT1369419E/pt unknown
- 2002-03-11 MX MXPA03008134A patent/MXPA03008134A/es active IP Right Grant
- 2002-03-11 BR BR0208027-3A patent/BR0208027A/pt not_active IP Right Cessation
- 2002-03-11 PL PL365100A patent/PL218750B1/pl unknown
- 2002-03-11 RU RU2003127677/04A patent/RU2299202C2/ru not_active IP Right Cessation
- 2002-03-11 AT AT05109059T patent/ATE522513T1/de active
- 2002-03-11 TW TW091104451A patent/TWI317359B/zh not_active IP Right Cessation
- 2002-03-11 NZ NZ528120A patent/NZ528120A/en not_active IP Right Cessation
- 2002-03-11 ES ES02705096T patent/ES2286230T3/es not_active Expired - Lifetime
- 2002-03-11 DK DK05109059.5T patent/DK1612208T3/da active
- 2002-03-11 IL IL15770102A patent/IL157701A0/xx unknown
- 2002-03-11 AU AU2002238855A patent/AU2002238855B2/en not_active Ceased
- 2002-03-11 WO PCT/JP2002/002245 patent/WO2002072564A1/ja not_active Ceased
- 2002-03-11 AT AT02705096T patent/ATE362924T1/de active
- 2002-03-11 HU HU0400155A patent/HU230056B1/hu not_active IP Right Cessation
- 2002-03-11 US US10/471,673 patent/US7235667B2/en not_active Expired - Fee Related
- 2002-03-11 CN CNB028097904A patent/CN1294126C/zh not_active Expired - Fee Related
2003
- 2003-09-02 IL IL157701A patent/IL157701A/en not_active IP Right Cessation
- 2003-09-03 ZA ZA2003/06884A patent/ZA200306884B/en unknown
- 2003-09-10 NO NO20034007A patent/NO329682B1/no not_active IP Right Cessation
- 2003-12-24 JP JP2003427226A patent/JP3741120B2/ja not_active Expired - Fee Related
2005
- 2005-08-26 JP JP2005245763A patent/JP4432051B2/ja not_active Expired - Fee Related
- 2005-09-30 US US11/239,406 patent/US7629369B2/en not_active Expired - Fee Related
2009
- 2009-10-21 US US12/603,194 patent/US8088802B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1369419A4 (en)	2005-03-16
PT1369419E (pt)	2007-08-16
CZ20032452A3 (cs)	2003-11-12
US7629369B2 (en)	2009-12-08
DE60220255T2 (de)	2008-01-17
TWI317359B (en)	2009-11-21
JP3555620B2 (ja)	2004-08-18
JP3741120B2 (ja)	2006-02-01
RU2299202C2 (ru)	2007-05-20
US20050124672A1 (en)	2005-06-09
WO2002072564A1 (en)	2002-09-19
US7235667B2 (en)	2007-06-26
DK1612208T3 (da)	2011-12-12
ATE362924T1 (de)	2007-06-15
PT1612208E (pt)	2011-10-12
JP2006028193A (ja)	2006-02-02
JP4432051B2 (ja)	2010-03-17
KR20030082978A (ko)	2003-10-23
DE60220255D1 (de)	2007-07-05
CZ304035B6 (cs)	2013-08-28
PL365100A1 (en)	2004-12-27
EP1612208A3 (en)	2006-12-06
NO20034007D0 (no)	2003-09-10
EP1612208B1 (en)	2011-08-31
NO329682B1 (no)	2010-11-29
KR100886854B1 (ko)	2009-03-05
IL157701A (en)	2010-06-30
US8088802B2 (en)	2012-01-03
US20100041708A1 (en)	2010-02-18
US20060030713A1 (en)	2006-02-09
NZ528120A (en)	2006-05-26
AU2002238855B2 (en)	2007-12-06
RU2003127677A (ru)	2005-03-27
CN1294126C (zh)	2007-01-10
IL157701A0 (en)	2004-03-28
ZA200306884B (en)	2005-03-30
HU230056B1 (hu)	2015-06-29
DK1369419T3 (da)	2007-09-24
CA2439604A1 (en)	2002-09-19
EP1369419A1 (en)	2003-12-10
JPWO2002072564A1 (ja)	2004-07-02
PL218750B1 (pl)	2015-01-30
HUP0400155A2 (hu)	2004-08-30
ATE522513T1 (de)	2011-09-15
JP2004149545A (ja)	2004-05-27
CN1509278A (zh)	2004-06-30
ES2286230T3 (es)	2007-12-01
EP1369419B1 (en)	2007-05-23
EP1612208A2 (en)	2006-01-04
HUP0400155A3 (en)	2007-05-02
BR0208027A (pt)	2004-12-28
CA2439604C (en)	2012-05-01
MXPA03008134A (es)	2004-03-10

Legal Events

Date	Code	Title	Description
2017-10-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20034007D0 (no)	2003-09-10	N-fenylarylsulfonamidforbindelse, legemiddel inneholdende forbindelsen somaktiv bestanddel, mellomprodukt for forbindelsen, ogfremgangsmåter for fremstilling av samme
DE60018064D1 (de)	2005-03-17	Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
GEP20094723B (en)	2009-07-10	Tetraazabenzo [e] azulene derivatives and analogs thereof
NO20032510L (no)	2003-06-03	Organiske forbindelser
ES2195943T3 (es)	2003-12-16	Compuestos heteroaromaticos biciclicos y triciclicos.
BG106095A (bg)	2002-06-28	Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
NZ514661A (en)	2003-06-30	alpha-substituted carboxylic acid derivatives and their use as therapeutic agents in pharmaceutical compositions
DK1326613T4 (da)	2007-09-03	Anvendelse af substituerede imidazo[1,2-a] pyridin-, -pyrimidin- og -pyrazin-3-yl-amin-derivater til fremstilling af lægemidler til NOS-inhibering
WO2003024965A3 (en)	2004-07-08	Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
IS2718B (is)	2011-02-15	Taxól-eflandi efnasambönd
HK1046405A1 (zh)	2003-01-10	作为nmda受体拮抗剂用於治疗疼痛的取代的1，5-二氢吡咯-2-酮衍生物
SE0102036D0 (sv)	2001-06-08	Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
DE60039878D1 (de)	2008-09-25	XENON ALS NMDA-ANTOGONIST zur Neuroprotektion
WO2001047913A3 (de)	2002-04-25	Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
DE60022895D1 (de)	2006-02-09	Pdgf-rezeptor-kinase hemmende verbindungen, deren herstellung, reinigung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
WO2002060423A3 (en)	2003-04-10	Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
DK1228758T3 (da)	2007-10-29	Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
WO1999004770A3 (en)	1999-04-15	A pharmaceutical composition active in reducing production of mcp-1 protein
WO2003018010A1 (en)	2003-03-06	Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
IL163608A (en)	2013-12-31	Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
BG107208A (bg)	2003-07-31	Аморфна тораземидна модификация
ATE247963T1 (de)	2003-09-15	Medikament zur behandlung von glaukoma und ischämischer retinopathie
JP2006503049A5 (no)	2006-07-27
JP2003502270A5 (no)	2006-01-05
BR9814660A (pt)	2007-11-20	compostos de éter cìclico piperidinilaminometil-trifluorometìlico como antagonista da substáncia p e composição farmacêutica